Sensor innovations allow vital signs to be measured at home with clinical precision, samples can be tested at the point of care, and then sample versions do not need to be sent to a remote laboratory for processing, producing faster results to accelerate diagnosis rates. The latest multi-parameter wearable sensors can combine vital signs with other metrics, such as movement and sleep, and put medical data in the context of a patient's lifestyle habits.

                           

 

                                     

 

A massive transformation of healthcare approaches was already underway before the emergence of SARS-CoV-2, the virus that causes COVID-19, to power medical innovation. Prior to the last two years of the pandemic, with the general ease of mobile broadband connectivity and the development of sophisticated sensing technologies, the aging of societies in developed countries was driving the choice of more personalized digital or remote methods for monitoring and confirming patients. As the COVID-19 pandemic puts pressure on limited hospital equipment, diagnostic and treatment service providers are accelerating the implementation of new technologies for testing and detection outside hospitals. Sensor innovations allow vital signs to be measured at home with clinical precision, samples can be tested at the point of care, and then sample versions do not need to be sent to a remote laboratory for processing, producing faster results to accelerate diagnosis rates.

 

This marks a break with decades of standardized diagnostic and treatment procedures. In the traditional medical model, patients visit hospitals and get tested when they have an obvious illness or when they have a routine annual checkup. These tests are usually sent out of the lab for analysis before a diagnosis or health assessment. In many cases, this diagnosis will be made long after the initial consultation and based on a single snapshot of the patient's condition.

 

This treatment approach makes sense when the complex equipment required to monitor vital signs and disease is rare and can only be used in hospitals or other specialized medical institutions.the development of new medical sensing technologies has created a standard for a very different concept of diagnosis and treatment. Unlike the large fixed diagnostic and treatment monitoring equipment commonly used in hospitals, the new machines applied to patient monitoring methods:

(1). Small size, even can wear;
(2). Low power consumption, so they can run on batteries;
(3) Provide accurate clinical grade measurement.

 

This allows diagnosis, treatment, monitoring and testing to be carried out in local facilities such as a GP's clinic or the patient's home. To bring even more convenience to patients, patches and other wearables can be operated continuously and discreetly from anywhere for easy 24/7 monitoring.

                 

 

                                 

 

 

Part of the motivation to implement new real-time monitoring technologies due to scarce resources. COVID-19 - When infections peaked in 2020, the pressure on hospitals confirmed that the healthcare system was quickly overwhelmed by the growing demand for acute care services. Therefore, moving patients whose vital signs must be monitored from hospital beds to clinics or their own homes is a sensible long-term response.
But just as importantly, testing using a portable or wearable device can provide more useful data and produce better patient outcomes. New medical monitoring technologies allow scaling and tracking of vital signs such as heartbeat, heart rate variability, and blood oxygen saturation (SpO2) and temperature. Based on ongoing regulation, it is not difficult to spot conditions and methods that practitioners cannot detect when dating patients. The parallel development of artificial intelligence (AI) diagnostic technology represents the automatic monitoring of data flows.

 

Instead of swallowing a patient's doctor with data, this AI-based approach applies technology to monitor vital signs in the background and only raises the flag if the patient has to make a personal intervention. Based on examining and interpreting precursor signals for future prevalence, patients and doctors can work together to change medications, lifestyle habits, or diet to avoid illnesses that occur during hospital visits to acute care units.

 

In addition, testing in a home or care facility can reveal the physical condition of the patient concerned in real life, rather than in the artificial and generally stressful environment of a hospital ward. The latest multi-parameter wearable sensors can combine vital signs with other metrics, such as movement and sleep, and put medical data in the context of a patient's lifestyle habits.

 

 

The result of a series of developments in semiconductor technology and computer science in the 21st century is the introduction of this new method of patient monitoring.In the optoelectronics industry, photoelectric volumetric pulse waves (PPG) have been developed to use minimally invasive optics to calculate heart rate, respiratory rate, and respiration rate SpO2. Tiny MEMS motion sensors can also measure patient activity, such as movement and sleep, placing vital signs in the pre - and post-text.

 

In hospitals, many of the devices used to monitor vital signs are huge and power-hungry. This measurement function is done at the chip level, where Analog Devices and other semiconductor manufacturers can build medical patches and other products for the skin. These products can run on battery power for days or weeks and wirelessly transmit measurements to host devices, such as smart machines. According to the host, the measurement results can be securely uploaded to the cloud diagnostic service, which can convert the initial electrical signal stream into actionable information in diagnosis and treatment.

 

 

It is one thing to describe the functional specifications of a semiconductor and a computing system. These requirements allow patients to wear a smart bracelet or patch to detect their vital signs. Using these technologies in a specific product to implement a solution is another matter.

 

At Analog Devices, we realize that our service to healthcare technology innovators may start with semiconductor technology, but it doesn't end there. Therefore, we offer our applications to users through technical experts and authorities in the medical market.

 

It is the job of medical authorities to have a comprehensive understanding of the key features of regulations and their market characteristics, such as regulations and data privacy. Users developing complex medical products can innovate faster, with more freedom and confidence to succeed because they are supported by experts who understand not only their technology, but also their applications.

 

In the vital signs monitoring industry, this use of expertise is supported by development platforms. For example, the Vital Signs Monitoring (VSM) Research Watch is a multi-parameter open development platform. It has a suite of sensors, can be selected in convenient wearable sizes, and provides a continuous vital sign measurement for developing biomedical algorithms.

 

VSM selects watch PPG to measure ECG of heart rate and heart rate variability. MEMS accelerometers are used to improve and inform algorithms that are sensitive to motion artifacts. Sensors on the watch measure temperature and impedance, and these values are used to detect pressure and body composition in the algorithm. These capabilities are suitable for research in medical and academic institutions to evaluate new use cases for remote patient supervision.

 

The payoff of removing patient testing from hospitals is clear. ADI's powerful company and other development platforms VSM Watches use precision, low-power, microcomponents such as sensors, analog-to-digital converters, and digital signal converters to lay the foundation for innovative diagnostic and treatment device manufacturers to build future monitoring systems.